The analysis of xenobiotics in breast milk is crucial for understanding the impact of early-life exposure on infant health. This mini-review highlights some recent advancements in mass spectrometry, focusing on SCIEX MS systems, to detect and quantify a wide range of xenobiotics in breast milk, an important nutrient source for infants. Advanced LC-MS/MS methods have been developed to achieve high sensitivity, with detection limits reaching picogram to nanogram per milliliter levels. These methods allow for the identification of xenobiotics like plasticizers and perfluorinated substances, as well as novel detections of compounds such as pyrrolizidine and tropane alkaloids in breast milk. The review also showcases and discusses the use of LC-HRMS/MS-based non-targeted analysis for profiling xenobiotics in breast milk and stool samples from mother-infant pairs. The approach was able to identify thousands of chemical features, revealing the overlap and distinct chemical patterns across matrices. The LC-HRMS/MS non-targeted analysis has proven to provide new insights into how the chemical exposome interacts with the gut microbiome, highlighting potential health risks associated with dietary and environmental exposures during early development.
xenobiotics, suspect screening, breast milk, infants, LC-MS/MS
[1] M. Krausová et al., “Understanding the Chemical Exposome During Fetal Development and Early Childhood: A Review,” Annu Rev Pharmacol Toxicol, vol. 63, pp. 517–540, Jan. 2023, doi: 10.1146/ANNUREV-PHARMTOX-051922-113350.
[2] M. Z. Hossain, M. L. Feuerstein, Y. Gu, and B. Warth, “Scaling up a targeted exposome LC-MS/MS biomonitoring method by incorporating veterinary drugs and pesticides,” Anal Bioanal Chem, vol. 416, no. 19, pp. 4369–4382, Aug. 2024, doi: 10.1007/S00216-024-05374-X.
[3] C. N. Ezekiel et al., “Mycotoxin exposure biomonitoring in breastfed and non-exclusively breastfed Nigerian children,” Environ Int, vol. 158, Jan. 2022, doi: 10.1016/j.envint.2021.106996.
[4] L. Chen, P. P. J. Mulder, J. Louisse, A. Peijnenburg, S. Wesseling, and I. M. C. M. Rietjens, “Risk assessment for pyrrolizidine alkaloids detected in (herbal) teas and plant food supplements,” Regul. Toxicol. Pharmacol., vol. 86, pp. 292–302, Jun. 2017, doi: 10.1016/j.yrtph.2017.03.019.
[5] M. E. Schiano, A. Abduvakhidov, M. Varra, and S. Albrizio, “Aptamer-Based Biosensors for the Analytical Determination of Bisphenol A in Foodstuffs,” Applied Sciences (Switzerland), vol. 12, no. 8, Apr. 2022, doi: 10.3390/APP12083752.
[6] M. Fisher et al., “Paraben Concentrations in Maternal Urine and Breast Milk and Its Association with Personal Care Product Use,” Environ Sci Technol, vol. 51, no. 7, pp. 4009–4017, Apr. 2017, doi: 10.1021/ACS.EST.6B04302.
[7] I. C. Shaw, “Chemical residues, food additives, and natural toxicants in food—the cocktail effect,” Int. J. Food Sci. Tech., vol. 49, no. 10, pp. 2149–2157, 2014, doi: 10.1111/ijfs.12606.
[8] M. Krausová, K. I. Ayeni, L. Wisgrill, C. N. Ezekiel, D. Braun, and B. Warth, “Trace analysis of emerging and regulated mycotoxins in infant stool by LC-MS/MS,” Anal Bioanal Chem, vol. 414, no. 25, pp. 7503–7516, Oct. 2022, doi: 10.1007/S00216-021-03803-9.
[9] I. Mädge, L. Cramer, I. Rahaus, G. Jerz, P. Winterhalter, and T. Beuerle, “Pyrrolizidine alkaloids in herbal teas for infants, pregnant or lactating women,” Food Chem., vol. 187, pp. 491–498, Nov. 2015, doi: 10.1016/j.foodchem.2015.04.067.
[10] Z. Lu et al., “Levels of polyphenols and phenolic metabolites in breast milk and their association with plant-based food intake in Hong Kong lactating women,” Food Funct, vol. 12, no. 24, pp. 12683–12695, Dec. 2021, doi: 10.1039/D1FO02529E.
[11] S. Berger, I. Oesterle, K. I. Ayeni, C. N. Ezekiel, A. Rompel, and B. Warth, “Polyphenol exposure of mothers and infants assessed by LC–MS/MS based biomonitoring in breast milk,” Anal Bioanal Chem, vol. 416, no. 7, pp. 1759–1774, Mar. 2024, doi: 10.1007/S00216-024-05179-Y.
[12] B. J. Song, Z. E. Jouni, and M. G. Ferruzzi, “Assessment of phytochemical content in human milk during different stages of lactation,” Nutrition, vol. 29, no. 1, pp. 195–202, Jan. 2013, doi: 10.1016/J.NUT.2012.07.015.
[13] N. Sillner et al., “Longitudinal Profiles of Dietary and Microbial Metabolites in Formula- and Breastfed Infants,” Front Mol Biosci, vol. 8, May 2021, doi: 10.3389/FMOLB.2021.660456.
[14] D. Braun, M. Eiser, H. Puntscher, D. Marko, and B. Warth, “Natural contaminants in infant food: The case of regulated and emerging mycotoxins,” Food Control, vol. 123, p. 107676, May 2021, doi: 10.1016/j.foodcont.2020.107676.
[15] I. Oesterle, K. I. Ayeni, C. N. Ezekiel, D. Berry, A. Rompel, and B. Warth, “Insights into the early-life chemical exposome of Nigerian infants and potential correlations with the developing gut microbiome,” Environ Int, vol. 188, Jun. 2024, doi: 10.1016/j.envint.2024.108766.
[16] L. R. Brink et al., “Neonatal diet alters fecal microbiota and metabolome profiles at different ages in infants fed breast milk or formula,” American Journal of Clinical Nutrition, vol. 111, no. 6, pp. 1190–1202, Jun. 2020, doi: 10.1093/ajcn/nqaa076.
[17] J. M. Braun, “Early-life exposure to EDCs: role in childhood obesity and neurodevelopment,” Nature Reviews Endocrinology 2016 13:3, vol. 13, no. 3, pp. 161–173, Nov. 2016, doi: 10.1038/nrendo.2016.186.
[18] J. J. Heindel et al., “Developmental Origins of Health and Disease: Integrating Environmental Influences,” Endocrinology, vol. 156, no. 10, pp. 3416–3421, Oct. 2015, doi: 10.1210/EN.2015-1394.
[19] J. H. Kim, N. Moon, E. Ji, and H. B. Moon, “Effects of postnatal exposure to phthalate, bisphenol a, triclosan, parabens, and per- and poly-fluoroalkyl substances on maternal postpartum depression and infant neurodevelopment: a korean mother-infant pair cohort study,” Environmental Science and Pollution Research, vol. 30, no. 42, pp. 96384–96399, Sep. 2023, doi: 10.1007/S11356-023-29292-0.
[20] J. D. Meeker, “Exposure to environmental endocrine disruptors and child development,” Arch. Pediatr. Adolesc. Med., vol. 166, no. 10, pp. 952–958, 2012, doi: 10.1001/archpediatrics.2012.241.
[21] J. M. Braun, “Early-life exposure to EDCs: Role in childhood obesity and neurodevelopment,” Nat Rev Endocrinol, vol. 13, no. 3, pp. 161–173, Mar. 2017, doi: 10.1038/NRENDO.2016.186.
[22] H. Wopereis, R. Oozeer, K. Knipping, C. Belzer, and J. Knol, “The first thousand days - intestinal microbiology of early life: Establishing a symbiosis,” Pediatric Allergy and Immunology, vol. 25, no. 5, pp. 428–438, 2014, doi: 10.1111/PAI.12232.
[23] S. M. Henning et al., “Pomegranate juice alters the microbiota in breast milk and infant stool: a pilot study,” Food Funct, vol. 13, no. 10, pp. 5680–5689, May 2022, doi: 10.1039/D2FO00280A.
[24] G. Boudry et al., “The Relationship Between Breast Milk Components and the Infant Gut Microbiota,” Front Nutr, vol. 8, Mar. 2021, doi: 10.3389/FNUT.2021.629740.
[25] K. I. Ayeni, D. Berry, L. Wisgrill, B. Warth, and C. N. Ezekiel, “Early-life chemical exposome and gut microbiome development: African research perspectives within a global environmental health context,” Trends Microbiol, vol. 30, no. 11, pp. 1084–1100, Nov. 2022, doi: 10.1016/j.tim.2022.05.008.
[26] D. Seki et al., “Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damage,” Cell Host Microbe, vol. 29, no. 10, pp. 1558-1572.e1556, Oct. 2021, doi: 10.1016/j.chom.2021.08.004.
[27] S. L. Collins and A. D. Patterson, “The gut microbiome: an orchestrator of xenobiotic metabolism,” Acta Pharm Sin B, vol. 10, no. 1, pp. 19–32, Jan. 2020, doi: 10.1016/j.apsb.2019.12.001.
[28] M. Flasch, V. Fitz, E. Rampler, C. N. Ezekiel, G. Koellensperger, and B. Warth, “Integrated Exposomics/Metabolomics for Rapid Exposure and Effect Analyses,” JACS Au, vol. 2, no. 11, pp. 2548–2560, Nov. 2022, doi: 10.1021/JACSAU.2C00433.
[29] K. Preindl et al., “A generic liquid chromatography-tandem mass spectrometry exposome method for the determination of xenoestrogens in biological matrices,” Anal. Chem., vol. 91, no. 17, pp. 11334–11342, Sep. 2019, doi: 10.1021/acs.analchem.9b02446.
[30] K. I. Ayeni et al., “Biomonitoring of Dietary Mycotoxin Exposure and Associated Impact on the Gut Microbiome in Nigerian Infants,” Environ Sci Technol, vol. 58, no. 5, pp. 2236–2246, Feb. 2024, doi: 10.1021/ACS.EST.3C07786.
[31] T. Jamnik et al., “Next-generation biomonitoring of the early-life chemical exposome in neonatal and infant development,” Nat Commun, vol. 13, no. 1, Dec. 2022, doi: 10.1038/S41467-022-30204-Y.
[32] S. A. Ali, D. Mittal, and G. Kaur, “In-situ monitoring of xenobiotics using genetically engineered whole-cell-based microbial biosensors: recent advances and outlook,” World Journal of Microbiology and Biotechnology 2021 37:5, vol. 37, no. 5, pp. 1–24, Apr. 2021, doi: 10.1007/S11274-021-03024-3.
[33] Y. Zharykbasov et al., “Studying the concentration of xenobiotics in milk and developing the biosensor method for their rapid determination,” Heliyon, vol. 9, no. 8, p. e19026, Aug. 2023, doi: 10.1016/J.HELIYON.2023.E19026.
[34] J. Guo and T. Huan, “Comparison of Full-Scan, Data-Dependent, and Data-Independent Acquisition Modes in Liquid Chromatography-Mass Spectrometry Based Untargeted Metabolomics,” Anal Chem, vol. 92, no. 12, pp. 8072–8080, Jun. 2020, doi: 10.1021/ACS.ANALCHEM.9B05135.
[35] B. Warth et al., “Exposome-scale investigations guided by global metabolomics, pathway analysis, and cognitive computing,” Anal Chem, vol. 89, no. 21, pp. 11505–11513, Nov. 2017, doi: 10.1021/ACS.ANALCHEM.7B02759.
[36] Y. Lai et al., “High-Resolution Mass Spectrometry for Human Exposomics: Expanding Chemical Space Coverage,” Environ Sci Technol, Jul. 2024, doi: 10.1021/ACS.EST.4C01156.
[37] M. Flasch, G. Koellensperger, and B. Warth, “Comparing the sensitivity of a low- and a high-resolution mass spectrometry approach for xenobiotic trace analysis: An exposome-type case study,” Anal Chim Acta, vol. 1279, p. 341740, Oct. 2023, doi: 10.1016/J.ACA.2023.341740.